21+ Years of Experience in CDMO Biologics
Curia is proud to offer a comprehensive suite of services and solutions for mRNA therapeutics, monoclonal antibodies and recombinant proteins using the latest technology, from discovery to clinic.
Partnering to Expedite Your
Product’s Success
Discovery
Make the Most of Your Molecule
End-to-end CDMO biologics discovery capabilities from antibody discovery to lead selection/optimization for complex biological clinical programs
Development
From Validation to Sterile Fill-Finish
Curia gives you an inside track with stable CHO cell line development, upstream/downstream process development, and the ability to provide start-to-finish development of sterile fill-finish products in various formats including vials, pre-filled syringes, and cartridges
Manufacturing
Rely on Our Expertise
Curia can provide GMP manufacturing services that work with your needs while our multi-site capabilities approach ensures you maintain engagement and complete control during the entire life cycle
